These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36807334)

  • 21. Use of the local lymph node assay in the evaluation of the sensitizing potential of pharmaceutical process intermediates.
    Durand G; de Burlet G; Virat M; Nauman BD
    Contact Dermatitis; 2003 Sep; 49(3):148-54. PubMed ID: 14678211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
    Schneider K; Akkan Z
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The local lymph node assay: past, present and future.
    Kimber I; Dearman RJ; Basketter DA; Ryan CA; Gerberick GF
    Contact Dermatitis; 2002 Dec; 47(6):315-28. PubMed ID: 12581276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The local lymph node assay and skin sensitization testing.
    Kimber I; Dearman RJ
    Methods Mol Biol; 2010; 598():221-31. PubMed ID: 19967517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Skin irritation and sensitization: mechanisms and new approaches for risk assessment.
    Basketter D; Darlenski R; Fluhr JW
    Skin Pharmacol Physiol; 2008; 21(4):191-202. PubMed ID: 18509253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A chemical dataset for evaluation of alternative approaches to skin-sensitization testing.
    Gerberick GF; Ryan CA; Kern PS; Dearman RJ; Kimber I; Patlewicz GY; Basketter DA
    Contact Dermatitis; 2004 May; 50(5):274-88. PubMed ID: 15209809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin sensitization risk assessment: Considering available data for weight of evidence assessments.
    Lewandowski TA; Cohen JM
    Regul Toxicol Pharmacol; 2016 Dec; 82():186-187. PubMed ID: 27681532
    [No Abstract]   [Full Text] [Related]  

  • 29. Correlation between experimental human and murine skin sensitization induction thresholds.
    Api AM; Basketter D; Lalko J
    Cutan Ocul Toxicol; 2015; 34(4):298-302. PubMed ID: 25430073
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of the LLNA:BrdU-ELISA for Skin Sensitization Hazard Assessment.
    Lehmann DM
    Methods Mol Biol; 2018; 1803():101-116. PubMed ID: 29882136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantitative risk assessment for skin sensitisation: consideration of a simplified approach for hair dye ingredients.
    Goebel C; Diepgen TL; Krasteva M; Schlatter H; Nicolas JF; Blömeke B; Coenraads PJ; Schnuch A; Taylor JS; Pungier J; Fautz R; Fuchs A; Schuh W; Gerberick GF; Kimber I
    Regul Toxicol Pharmacol; 2012 Dec; 64(3):459-65. PubMed ID: 23069142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin sensitization potency of isoeugenol and its dimers evaluated by a non-radioisotopic modification of the local lymph node assay and guinea pig maximization test.
    Takeyoshi M; Iida K; Suzuki K; Yamazaki S
    J Appl Toxicol; 2008 May; 28(4):530-4. PubMed ID: 17929237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local lymph node assay: use in hazard and risk assessment.
    Dearman RJ; Basketter DA; Kimber I
    J Appl Toxicol; 1999; 19(5):299-306. PubMed ID: 10513674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods.
    Gerberick GF; Ryan CA; Kern PS; Schlatter H; Dearman RJ; Kimber I; Patlewicz GY; Basketter DA
    Dermatitis; 2005 Dec; 16(4):157-202. PubMed ID: 16536334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of diethylthiourea and ethyl isothiocyanate as potent skin allergens in chloroprene rubber.
    Ramzy AG; Hagvall L; Pei MN; Samuelsson K; Nilsson U
    Contact Dermatitis; 2015 Mar; 72(3):139-46. PubMed ID: 25532938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative risk assessment of allergens leaching from menstrual hygiene products.
    Marcelis Q; Gatzios A; Deconinck E; Rogiers V; Desmedt B; Vanhaecke T
    Regul Toxicol Pharmacol; 2022 Nov; 135():105260. PubMed ID: 36067853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of in vitro skin penetration measurements to confirm and refine the quantitative skin sensitization risk assessment of methylisothiazolinone.
    Rothe H; Ryan CA; Page L; Vinall J; Goebel C; Scheffler H; Toner F; Roper C; Kern PS
    Regul Toxicol Pharmacol; 2017 Dec; 91():197-207. PubMed ID: 29080845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictive identification of human skin sensitization thresholds.
    Basketter DA; Clapp C; Jefferies D; Safford B; Ryan CA; Gerberick F; Dearman RJ; Kimber I
    Contact Dermatitis; 2005 Nov; 53(5):260-7. PubMed ID: 16283904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of the risk assessment paradigm to the induction of allergic contact dermatitis.
    Felter SP; Ryan CA; Basketter DA; Gilmour NJ; Gerberick GF
    Regul Toxicol Pharmacol; 2003 Feb; 37(1):1-10. PubMed ID: 12662904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inter-laboratory validation of the modified murine local lymph node assay based on 5-bromo-2'-deoxyuridine incorporation.
    Kojima H; Takeyoshi M; Sozu T; Awogi T; Arima K; Idehara K; Ikarashi Y; Kanazawa Y; Maki E; Omori T; Yuasa A; Yoshimura I
    J Appl Toxicol; 2011 Jan; 31(1):63-74. PubMed ID: 20677212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.